Pfizer; NGENLA; CellTrans; Ipsen; Aeras; Gates Foundation; Cognition Therapeutics; Astellas; Bayer
Today in FirstWord Pharma 's Industry News ???, we cover:
? US approves Pfizer's paediatric growth hormone deficiency drug Ngenla
?? FDA clears CellTrans' cell therapy Lantidra for type 1 diabetes
?? Ipsen's palovarotene wins FDA panel backing for rare bone disease
?? Gates-backed effort invests $550 million on new TB vaccine study
?? Cognition Therapeutics slumps on Alzheimer's drug study readout
?? Astellas touts more Phase III data for nonhormonal menopause drug Veozah
?? Bayer progresses Parkinson's cell therapy to next stage after early study success
?? To learn more about these top stories, sign up to receive our newsletter ?? https://firstwordpharma.com/register and never miss the important news and insights impacting the?#pharma?industry!